|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.440 USD | +11.63% |
|
+25.22% | -67.99% |
Company Valuation: FibroBiologics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 70.17 | 14.96 | 9.588 | - | - |
| Change | - | -78.68% | -35.91% | - | - |
| Enterprise Value (EV) | 70.17 | 14.96 | 9.588 | 9.588 | 9.588 |
| Change | - | -78.68% | -35.91% | 0% | 0% |
| P/E | -5.88x | -0.54x | -0.48x | -0.82x | -0.75x |
| PBR | - | - | - | - | - |
| PEG | 0.1x | -0x | 0x | 0x | -0.09x |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0.52x | -0.42x | -0.34x |
| EV / FCF | -0x | - | -0.54x | -0.4x | -0.3x |
| FCF Yield | -17.2% | - | -185% | -249% | -336% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.8 | -8.4 | -3 | -1.763 | -1.913 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -13.74 | -16.65 | -18.53 | -22.95 | -28.37 |
| Net income 1 | -11.16 | -18.65 | -18.51 | -22.96 | -28.04 |
| Net Debt | - | - | - | - | - |
| Reference price 2 | 40.000 | 4.498 | 1.440 | 1.440 | 1.440 |
| Nbr of stocks (in thousands) | 1,754 | 3,326 | 6,658 | - | - |
| Announcement Date | 3/31/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43x | - | - | - | 8.59M | |
| 22.11x | 7.75x | 15.8x | 1.34% | 73.96B | |
| 36.85x | 9.53x | 29.23x | 0.04% | 64.66B | |
| -79.06x | 14.77x | -71.24x | -.--% | 27.32B | |
| -17.19x | 6.91x | -8.97x | -.--% | 27.86B | |
| 32.87x | 6.47x | 17.14x | -.--% | 25.97B | |
| 27.08x | 5.08x | 17.06x | -.--% | 19.98B | |
| 51.97x | 19.21x | 38.91x | 0.29% | 17.84B | |
| -1000000x | 41.19x | -1441.61x | -.--% | 16.24B | |
| 16.61x | 4.92x | 11.49x | -.--% | 13.3B | |
| Average | -99,990.92x | 12.87x | -154.69x | 0.19% | 28.71B | |
| Weighted average by Cap. | -56,559.10x | 10.91x | -72.87x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBLG Stock
- Valuation FibroBiologics, Inc.
Select your edition
All financial news and data tailored to specific country editions
